Real-time online monitoring of bioprocesses
Industrial biotechnology (IB) has the potential to create new markets while protecting the environment. With this in mind, the EU-funded BIOINDUSTRY 4.0 project will pave the way for IB to become a major manufacturing technology. Supporting the digitalisation of IB, the project will create new services delivered by European research infrastructure. These will address several challenges, focusing on the acceleration of bioprocess development pipelines. BIOINDUSTRY 4.0 will also develop data and metadata standards to generate high-quality, interoperable, multiscale bioprocess data. By developing data-driven approaches and exploiting AI to empower novel decision support systems and digital twins, the project will make it possible to control bioprocesses in real time.
Bioindustry4.0 Objective
Industrial Biotechnology (IB) is a Key Enabling Technology for the circular bio-economy, industrial renewal and European manufacturing autonomy. Its development forms a vital part of EU’s strategy to become climate neutral in 2050. For IB to become a major manufacturing technology, it must widen its use of advanced digital technologies. These will improve R&D efficiency, reducing time-to-market and costs. Moreover, for manufacturing, advanced digital technologies will drive distributed, autonomous and highly adaptable production systems. To support digitalization of IB, BIOINDUSTRY 4.0 will create new services delivered by European research infrastructures (RI). These services will address several challenges, focusing on the acceleration of bio-process development pipelines. Drawing on the complementary skills of its consortium, BIOINDUSTRY 4.0 will develop data-driven approaches, exploiting AI to empower novel decision support systems and digital twins, the latter being to better design bio-processes and enable their real-time online control. To complete these services, BIOINDUSTRY 4.0 will also develop data and metadata standards to generate high quality, interoperable multi-scale bio-process data, the technical basis for trusted data networks and process analytical devices to provide real-time online monitoring of bio-processes. Once deployed, these RI services will provide Users with access to cutting-edge technologies that can be used singly or in an integrated way, covering whole R&D pipelines. Integrated services will be delivered by a distributed RI, conferring Europe with a unique R&D test-bed for bio-process development and a competitive advantage with respect to global competition. To succeed, BIOINDUSTRY 4.0 brings together 6 EU RIs, 1 global company, 2 innovative EU SMEs and several research teams around an ambitious 4-year workplan that will be implemented in consultation with IB stakeholders, using a co-design strategy to specify goals.
Fields of science (EuroSciVoc):
- social sciences
- economics and business
- economics
- bioeconomy
- economics
- economics and business
Keywords:
- industrial biotechnology
- bio-process
- artificial intelligence
- digital twins
- decision support systems
- trusted data networks
- Process Analytical Technology
- Industry 4.0
Web page: https://www.bioindustry4.eu
Funding codes:- https://doi.org/10.3030/101094287
- Grant agreement ID: 101094287
- https://cordis.europa.eu/project/id/101094287
Bioindustry 4.0 falls under the following Horizon Europe programmes: "HORIZON.1.3 - Research infrastructures"; and "HORIZON.1.3.3 - The innovation potential of European Research Infrastructures and activities for Innovation and Training" under the topic of "HORIZON-INFRA-2022-TECH-01-01 - R&D for the next generation of scientific instrumentation, tools and methods".
Funder webpage: https://cordis.europa.eu/project/id/101094287
Related items
- People (16)
- Projects (5)
- Institutions (8)
- Investigations (2+6)
- Studies (5+8)
- Assays (10+3)
- Data files (41+3)
- Models (0+2)
- Publications (5)
- Presentations (3+11)
- Events (27+11)
- Documents (2+2)
- Observation Units (15+2)
Projects: Industrial-scale penicillin simulation
Institutions: Universität Koblenz
Projects: Scorpion antivenom nanobody production in Escherichia coli (Recombinant bispecific VHH), Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment
Institutions: INSAT - Institut National des Science Appliquees de Toulouse, INRAE
https://orcid.org/0000-0001-8290-1635
Expertise: Biotechnology, Industrial Biotechnology
Tools: Fermentation, Microbiology
Bioprocess engineer with extensive expertise in bioreactor process design, fermentation technologies, and protein production. Skilled in scaling up bioprocesses, experimental design, and process optimization.
Industrial-scale penicillin simulation
Industrial-scale penicillin simulation (IndPenSim) is a first principles mathematical model of a 100,000 Litre fermentation of an industrial strain of Penicillium chrysogenum validated using historical data collected from an industrial-scale penicillin fermentation process. Adapting a previously published structured model to describe penicillin fermentation and extending the model to include the main environmental effects of dissolved oxygen, ...
Programme: Bioindustry 4.0
Public web page: http://www.industrialpenicillinsimulation.com/
Start date: 1st Jan 2023
End date: 31st Dec 2026
Organisms: Penicillium chrysogenum
Hybrid Physics-Informed Neural Networks for Efficient Computational Modeling: A Workflow Framework Applied to Schwanniomyces occidentalis
Programme: Bioindustry 4.0
Public web page: Not specified
Start date: 1st Sep 2025
End date: 31st Dec 2028
Organisms: Schwanniomyces occidentalis
Bioindustry4.0 Work Package 7: Tools for high-quality datasets, requisite for data-driven methods and services
Real-time online monitoring of bioprocesses
Industrial biotechnology (IB) has the potential to create new markets while protecting the environment. With this in mind, the EU-funded BIOINDUSTRY 4.0 project will pave the way for IB to become a major manufacturing technology. Supporting the digitalisation of IB, the project will create new services delivered by European research ...
Programme: Bioindustry 4.0
Public web page: https://www.bioindustry4.eu/
Start date: 1st Jan 2023
End date: 31st Dec 2026
Organisms: Not specified
Programme: Bioindustry 4.0
Public web page: Not specified
Organisms: Komagataella (aka Pichia) pastoris
Scorpionism is a serious public health problem in tropical areas, especially in Africa, southern India, the Middle East, and Latin America. There are about 12 species of scorpions that are dangerous to humans and all belong to the Buthidae family. In particular, venom on scorpion Androctonus australis hector is particularly toxic to humans. Serotherapy uses antibodies or fragments of antibodies to target the neurotoxins of the scorpion venom. Nanobodies, camelid-derived antibodies, are more ...
Organisms: Escherichia coli
ROR ID: https://ror.org/0576by029
Department: Not specified
Country:
Greece
City: Marousi
Web page: https://www.athenarc.gr/
ROR ID: Not specified
Department: Not specified
Country:
France
City: Paris
Web page: http://institut.inra.fr/en
ROR ID: Not specified
Department: Not specified
Country:
France
City: Paris
Web page: https://www.inrae.fr/en
ROR ID: Not specified
Department: Not specified
Country:
France
City: Toulouse
Web page: http://www.insa-toulouse.fr
ROR ID: https://ror.org/03ayjn504
Department: Not specified
Country:
Mexico
City: Monterrey
Web page: https://tec.mx
We studied the production of scorpion antivenom nanobodies in high cell density microbioreactors. The BiolectorXT (Beckman) was used to screen different production strategies within the framework of a machine-learning model optimization.
Submitter: Susana Alonso Villela
Studies: Characterization of nanobody-producer strains in microbioreactors
Assays: Fed-batch culture of E. coli strains in microbioreactors
Snapshots: No snapshots
In the biopharmaceutical industry, nanobodies show promising properties for its application in serotherapy for serums targeting the most toxic components of scorpion venom. Nevertheless, the limited number of scientific publications on the production of nanobodies for antivenom productions poses a challenge. The reported yield is low (< 4 mg/L), biomass production is not reported, and the production in high cell density cultures have not been studied. Production conditions (temperature of ...
Submitter: Susana Alonso Villela
Studies: Characterization of E. coli WK6 strain under aerobic conditions, Characterization of E. coli WK6 strain under induction conditions, Recombinant nanobody CH10-12 and NbF12-10 production at low induction te..., Recombinant nanobody CH10-12 production at different induction temperatu...
Assays: Fed-batch culture of CH10-12 strain, induction at 28°C - BR02, Fed-batch culture of CH10-12 strain, induction at 29°C - BR06, Fed-batch culture of CH10-12 strain, induction at 30°C - BR03, Fed-batch culture of CH10-12 strain, induction at 32°C - BR07, Fed-batch culture of CH10-12 strain, induction at 33°C - BR04, Fed-batch culture of CH10-12 strain, induction at 37°C - BR05, Fed-batch culture of NbF12-10 strain, induction at 29°C - BR08, Fed-batch culture of WK6 strain, induction at 29°C - BR09, Fed-batch culture of WK6 strain, without induction - BR01
Snapshots: No snapshots
The screening of E. coli strains WK6, CH10-12 (2017), CH10-12 (2023), NbF12-10 (2017), and NbF12-10 (2023) was made in a BioLectorXT (Beckman) setting
Submitter: Susana Alonso Villela
Investigation: Scale-down effects of the nanobody producing E....
Assays: Fed-batch culture of E. coli strains in microbioreactors
Snapshots: No snapshots
Submitter: Susana Alonso Villela
Investigation: Effect of the induction temperature in nanobody...
Assays: Fed-batch culture of WK6 strain, without induction - BR01
Snapshots: No snapshots
Submitter: Susana Alonso Villela
Investigation: Effect of the induction temperature in nanobody...
Assays: Fed-batch culture of WK6 strain, induction at 29°C - BR09
Snapshots: No snapshots
Submitter: Susana Alonso Villela
Investigation: Effect of the induction temperature in nanobody...
Assays: Fed-batch culture of CH10-12 strain, induction at 29°C - BR06, Fed-batch culture of CH10-12 strain, induction at 32°C - BR07, Fed-batch culture of NbF12-10 strain, induction at 29°C - BR08
Snapshots: No snapshots
Submitter: Susana Alonso Villela
Investigation: Effect of the induction temperature in nanobody...
Assays: Fed-batch culture of CH10-12 strain, induction at 28°C - BR02, Fed-batch culture of CH10-12 strain, induction at 30°C - BR03, Fed-batch culture of CH10-12 strain, induction at 33°C - BR04, Fed-batch culture of CH10-12 strain, induction at 37°C - BR05
Snapshots: No snapshots
Culture of E. coli strains WK6, CH10-12 (2017), CH10-12 (2023), NbF12-10 (2017), and NbF12-10 (2017) at 28°C in a fed-batch microbioreactor setting.
Submitter: Susana Alonso Villela
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Scale-down effects of the nanobody producing E....
Organisms: Escherichia coli
SOPs: No SOPs
Data files: BiolectorXT data from the screening of E. coli ...
Snapshots: No snapshots
5L bioreactor culture of strain E. coli WK6 in a batch/fed-batch strategy at 37°C. Characterization of biomass growth and oxygen transfer
Submitter: Susana Alonso Villela
Assay type: Cultivation Experiment
Technology type: Fed-batch
Investigation: Effect of the induction temperature in nanobody...
Organisms: Escherichia coli
SOPs: No SOPs
Data files: BR01 samples, BioPAT MFCS data for BR01 - part 1, BioPAT MFCS data for BR01 - part 2, Data analysis of the BR01 culture, Gas analysis data for BR01
Snapshots: No snapshots
5L bioreactor culture of recombinant strain E. coli CH10-12 in a batch/fed-batch strategy at 37°C (BR02). Protein induction promoted when biomass reached 25 g cdw/L and at 28°C for 12 h
Submitter: Susana Alonso Villela
Assay type: Cultivation Experiment
Technology type: Fed-batch
Investigation: Effect of the induction temperature in nanobody...
Organisms: Escherichia coli
SOPs: No SOPs
Data files: BR02 samples, BioPAT MFCS data for BR02 - part 1, BioPAT MFCS data for BR02 - part 2, Gas analysis data for BR02 and BR03 and 1 hidden item
Snapshots: No snapshots
5L bioreactor culture of recombinant strain E. coli CH10-12. Protein induction promoter when biomass reached 30 g cdw/L and at 29°C for 38 h
Submitter: Susana Alonso Villela
Assay type: Cultivation Experiment
Technology type: Fed-batch
Investigation: Effect of the induction temperature in nanobody...
Organisms: Escherichia coli
SOPs: No SOPs
Data files: BR06 samples, BioPAT MFCS data for BR06 - part 1, BioPAT MFCS data for BR06 - part 2, Data analysis of the BR06 culture, Gas analysis data for BR06 and BR07
Snapshots: No snapshots
5L bioreactor culture of reference strain E. coli WK6. Protein induction promoter when biomass reached 25 g cdw/L and at 29°C for 28 h
Submitter: Susana Alonso Villela
Assay type: Cultivation Experiment
Technology type: Fed-batch
Investigation: Effect of the induction temperature in nanobody...
Organisms: Escherichia coli
SOPs: No SOPs
Data files: BR09 samples, BioPAT MFCS data for BR09 - part 1, BioPAT MFCS data for BR09 - part 2, Data analysis of the BR09 culture, Gas analysis data for BR08 and BR09
Snapshots: No snapshots
32 fed-batch cultures at 28°C
Creators: Susana Alonso Villela, Cesar ACEVES LARA, Juan Camilo Acosta Pavas
Submitter: Susana Alonso Villela
Excel file containing the data anlysis of the BR03 culture: mass balances, specific growth rate, bioreactor volume, oxygen uptake rate (OUR)
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
Excel file containing the data anlysis of the BR04 culture: mass balances, specific growth rate, bioreactor volume, oxygen uptake rate (OUR)
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
Excel file containing the data anlysis of the BR05 culture: mass balances, specific growth rate, bioreactor volume, oxygen uptake rate (OUR)
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
Excel file containing the data anlysis of the BR06 culture: mass balances, specific growth rate, bioreactor volume, oxygen uptake rate (OUR)
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
Abstract (Expand)
Authors: Brett Metcalfe, Juan Camilo Acosta-Pavas, Carlos Eduardo Robles-Rodriguez, George K. Georgakilas, Theodore Dalamagas, Cesar Arturo Aceves-Lara, Fayza Daboussi, Jasper J Koehorst, David Camilo Corrales
Date Published: 1st Mar 2025
Publication Type: Journal
DOI: 10.1016/j.compchemeng.2024.108991
Citation: Computers & Chemical Engineering 194:108991
Abstract (Expand)
Authors: Juan Camilo Acosta-Pavas, Carlos Eduardo Robles-Rodriguez, David Griol, Fayza Daboussi, Cesar Arturo Aceves-Lara, David Camilo Corrales
Date Published: 1st Aug 2024
Publication Type: Journal
DOI: 10.1016/j.compchemeng.2024.108736
Citation: Computers & Chemical Engineering 187:108736
Abstract (Expand)
Editor:
Date Published: 2024
Publication Type: Journal
DOI: 10.1016/B978-0-443-28824-1.50535-4
Citation: 34th European Symposium on Computer Aided Process Engineering / 15th International Symposium on Process Systems Engineering 53:3205-3210,Elsevier
Abstract (Expand)
Authors: Susana María Alonso Villela, Hazar Ghezal-Kraïem, Balkiss Bouhaouala-Zahar, Carine Bideaux, César Arturo Aceves Lara, Luc Fillaudeau
Date Published: 1st Feb 2021
Publication Type: Journal
DOI: 10.1007/s00253-021-11093-5
Citation: Appl Microbiol Biotechnol 105(3):1017-1030
Abstract (Expand)
Authors: Susana María Alonso Villela, Hazar Kraïem, Balkiss Bouhaouala‐Zahar, Carine Bideaux, César Arturo Aceves Lara, Luc Fillaudeau
Date Published: 1st Jun 2020
Publication Type: Journal
DOI: 10.1002/mbo3.1027
Citation: MicrobiologyOpen 9(6):1175-1182
The IBISBA Knowledge Hub (IBISBAKHub) is a data management platform designed to help researchers enhance the management of their research data. It offers an improved way to share, register, and organize the data and assets generated from research projects. The IBISBAKHub’s primary objective is to promote the adoption and implementation of FAIR Data principles.
IBISBA DIALS - Funded by the European Union (Grant agreement N°101131085). Views and opinions expressed are however those of the author(s) ...
Creator: Munazah Andrabi
Submitter: Brett Metcalfe
The IBISBA Knowledge Hub (IBISBAKHub) is a data management platform designed to help researchers enhance the management of their research data. It offers an improved way to share, register, and organize the data and assets generated from research projects. The IBISBAKHub’s primary objective is to promote the adoption and implementation of FAIR Data principles.
IBISBA DIALS - Funded by the European Union (Grant agreement N°101131085). Views and opinions expressed are however those of the author(s) ...
Creator: Jasper Koehorst
Submitter: Brett Metcalfe
Global results obtained from the 5 L bioreactor cultures of E. coli
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
The stakeholder workshop on IoT: Data integration from the lab took place on October 23rd, 2025 from 10:00-12:00 (CET). This two-hour workshop brought together experts and stakeholders to explore how laboratory data can be better integrated, managed, and applied using Internet of Things (IoT) technologies. The purpose of this event was to foster dialogue on the opportunities but also the challenges of IoT data acquisition within laboratory environments, exploring how connected equipment and sensors ...
Start Date: 23rd Oct 2025 (23rd Oct 2025 (Europe/Amsterdam))
End Date: 23rd Oct 2025 (23rd Oct 2025 (Europe/Amsterdam))
Event Website: https://www.bioindustry4.eu/
Country: Not specified
City: Not specified
5L bioreactor culture of_ E. coli _NbF12-10 at 29°C in nanobody production phase adding 1 mM IPTG to the bioreactor. Caracterization of nanobody production in glucose-limited conditions, using a constant glucose feed strategy of 4.5 g/h
Start Date: 19th Feb 2019 (19th Feb 2019 (Europe/Paris))
End Date: 21st Feb 2019 (21st Feb 2019 (Europe/Paris))
Event Website: Not specified
Country:
France
City: Toulouse
5L bioreactor culture of E. coli WK6 at 29°C in biomass production phase under induction conditions adding 1 mM IPTG to the bioreactor. Caracterization of biomass production in glucose-limited conditions, using a constant glucose feed strategy of 4.5 g/h
Start Date: 19th Feb 2019 (19th Feb 2019 (Europe/Paris))
End Date: 20th Feb 2019 (20th Feb 2019 (Europe/Paris))
Event Website: Not specified
Country:
France
City: Toulouse
5L bioreactor culture of E. coli NbF12-10 at 37°C in fed-batch phase. Caracterization of biomass production phase in glucose-limited conditions, using an exponential-like glucose feed strategy for a µ=0.38 h-1
Start Date: 19th Feb 2019 (19th Feb 2019 (Europe/Paris))
End Date: 19th Feb 2019 (19th Feb 2019 (Europe/Paris))
Event Website: Not specified
Country:
France
City: Toulouse
5L bioreactor culture of_ E. coli_ WK6 at 37°C in fed-batch phase. Caracterization of biomass production phase in glucose-limited conditions, using an exponential-like glucose feed strategy for a µ=0.38 h-1
Start Date: 19th Feb 2019 (19th Feb 2019 (Europe/Paris))
End Date: 19th Feb 2019 (19th Feb 2019 (Europe/Paris))
Event Website: Not specified
Country:
France
City: Toulouse
Procedure followed for the data treatment and analysis of 5L bioreactor cultures
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
Investigations: Effect of the induction temperature in nanobody...
Studies: Characterization of E. coli WK6 strain under ae..., Characterization of E. coli WK6 strain under in..., Recombinant nanobody CH10-12 and NbF12-10 produ..., Recombinant nanobody CH10-12 production at diff...
Assays: Fed-batch culture of CH10-12 strain, induction ..., Fed-batch culture of CH10-12 strain, induction ..., Fed-batch culture of CH10-12 strain, induction ..., Fed-batch culture of CH10-12 strain, induction ..., Fed-batch culture of CH10-12 strain, induction ..., Fed-batch culture of CH10-12 strain, induction ..., Fed-batch culture of NbF12-10 strain, induction..., Fed-batch culture of WK6 strain, induction at 2..., Fed-batch culture of WK6 strain, without induct...
Scorpionism is a serious public health problem in tropical areas, especially in Africa, southern India, the Middle East, and Latin America. There are about 12 species of scorpions that are dangerous to humans and all belong to the Buthidae family. In particular, venom on scorpion Androctonus australis hector is particularly toxic to humans. Serotherapy uses antibodies or fragments of antibodies to target the neurotoxins of the scorpion venom. Nanobodies, camelid-derived antibodies, are more ...
Creator: Susana Alonso Villela
Submitter: Susana Alonso Villela
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Download